Logo-ps
Pharm Sci. 2024;30(1): 135-142. doi: 10.34172/PS.2023.28

Research Article

Idarubicin versus Doxorubicin in Acute Myeloid Leukemia: A Parallel Randomized Trial with Pharmacoeconomic Analysis

Amany El Zeiny 1 * ORCID, Raafat Abdel-Fattah 2, Maggie Abbassie 3, Samar Farid 3

Cited by CrossRef: 0


   Indexing & Abstracting:

    

   

     

 

Director-in-Charge:
Prof. Khosro Adibkia

Editor-in-Chief:
Prof. Ali Shayanfar

 

 

Follower of ICMJE

Powered by: